115 related articles for article (PubMed ID: 6114738)
1. [Dose-dependent effects of ranitidine on the transmural potential difference of the stomach].
von Kleist D; Zschiedrich M; Stopik D; Hampel KE
Arzneimittelforschung; 1981; 31(6):1038-40. PubMed ID: 6114738
[TBL] [Abstract][Full Text] [Related]
2. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
von Kleist D; Gräf KJ; Dougherty FC; Hampel KE
Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
[TBL] [Abstract][Full Text] [Related]
3. [Ranitidine and transmural potential difference. Results with sodium taurocholate (author's transl)].
Müller P; Fischer N; Kather H; Simon B; Dammann HG
Dtsch Med Wochenschr; 1981 Nov; 106(47):1577-9. PubMed ID: 6118248
[TBL] [Abstract][Full Text] [Related]
4. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
[TBL] [Abstract][Full Text] [Related]
5. [Ranitidine: consequences on secretory function and gastric mucosa].
Vallot T; Cadiot G
Rev Med Suisse Romande; 1995 Oct; 115(10):773-80. PubMed ID: 7501929
[No Abstract] [Full Text] [Related]
6. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)].
von Kleist D; Staud R; Stopik D; Hampel HE
Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):110-4. PubMed ID: 6893819
[TBL] [Abstract][Full Text] [Related]
7. [Effect of cimetidine on the transmural gastric mucosal potential difference including the histological pattern of the gastric mucosa (author's transl)].
von Kleist D; Stopik D; Hampel KE
Z Gastroenterol; 1980 Apr; 18(4):185-90. PubMed ID: 7424072
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ranitidine in serum by high performance liquid chromatography.
Vandenberghe HM; MacLeod SM; Mahon WA; Lebert PA; Soldin SJ
Ther Drug Monit; 1980; 2(4):379-84. PubMed ID: 6111854
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
10. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion.
Mohammed R; Clark JS; Adams JF; Hearns JB; Crean GP
Clin Ther; 1981; 4(2):118-20. PubMed ID: 6117373
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
12. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
13. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
Batzri S; Harmon JW; Dyer J; Thompson WF
Mol Pharmacol; 1982 Jul; 22(1):41-7. PubMed ID: 6126804
[No Abstract] [Full Text] [Related]
14. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
15. H2 receptor antagonists: ultrastructure of canine parietal cells after long term treatment with ranitidine.
Ainge G; Poynter D
Scand J Gastroenterol Suppl; 1981; 70():143-54. PubMed ID: 6118943
[No Abstract] [Full Text] [Related]
16. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
18. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of ranitidine on gastric luminal pH and mucosal PCO2 during the first day in the ICU.
Jakob SM; Parviainen I; Ruokonen E; Uusaro A; Takala J
Acta Anaesthesiol Scand; 2005 Mar; 49(3):390-6. PubMed ID: 15752407
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
